Featured Research

from universities, journals, and other organizations

Researchers Discover The Ultimate Adult Stem Cell

Date:
May 4, 2001
Source:
New York University Medical Center And School Of Medicine
Summary:
The ultimate adult stem cell appears to have been discovered--a cell in the bone marrow that can transform itself into almost any organ in the body, according to a new study by New York University School of Medicine, Yale University School of Medicine, and Johns Hopkins School of Medicine researchers.

NEW YORK, May 3 -- The ultimate adult stem cell appears to have been discovered--a cell in the bone marrow that can transform itself into almost any organ in the body, according to a new study by New York University School of Medicine, Yale University School of Medicine, and Johns Hopkins School of Medicine researchers.

"There is a cell in the bone marrow that can serve as the stem cell for most, if not all, of the organs in the body," says Neil Theise, M.D., Associate Professor of Pathology at NYU School of Medicine, who co-led the study. "This is an exciting study. Theoretically, any organ could be 2repaired using cells generated from this stem cell and bone-marrow-derived cells could be used to target gene therapy to a specific organ."

The new study is published in the May 4 issue of the journal Cell.

In the last three years, a growing number of studies have overturned long-held beliefs about stem cells in the bone marrow. It had been believed that in the adult, these bone marrow cells were committed only to making blood cells. But over the last three years, a growing number of studies have shown that these cells have surprising plasticity, and can transform themselves into mature cells of other organs such as skeletal muscle, bone, and brain. Dr. Theise and Dr. Diane Krause, Assistant Professor of Laboratory Medicine and Pathology at Yale University School of Medicine, were among the first to show that stem cells can become liver cells, as well, and the first to demonstrate this transformation in humans. Yet, until now, the stem cell from which these mature cells arose hadn't been identified.

In the new study, Dr. Saul Sharkis and colleagues at Johns Hopkins first purified stem cells in the bone marrow of male mice. Then they took just one of these cells and transplanted it into female mice that had their bone marrow destroyed by radiation. Eleven months later, the researchers found that the male cells had settled in the blood and bone marrow of the surviving female animals, using color dyes that light up the Y chromosome and other structures. The Y chromosome is only found in cells from males. When Drs. Theise and Krause looked, they found the male chromosome not only in the bone marrow and blood, as expected, but also in the tissue from the lung, esophagus, stomach, small and large intestines, liver, and skin.

"It had been thought that only embryonic stem cells had such wide-ranging potential," says Dr. Theise of NYU School of Medicine. "However, this study provides the strongest evidence yet that the adult body harbors stem cells that are as flexible as embryonic stem cells," he says.

"It's astounding that there are cells in our bone marrow that can become so many different cell types including blood, lung, GI tract and skin," says Dr. Krause of Yale University. "The challenges now are to elucidate how these changes occur and to harness these findings to develop therapies for many different human diseases."

Stem cells in the marrow may be recruited to a damaged organ where they will develop into the mature tissue of that organ in response to certain signals. However, Drs Theise and Krause speculate that any healthy adult cell with an intact genome can be reprogrammed to become a stem cell.

The study had two parts. In the first part, stem cells in the bone marrow were isolated and purified using a protocol developed by Dr. Sharkis. Bone marrow cells from male mice were spun in a centrifuge, partitioning cells according to their weight in a process called elutriation. Then the cells belonging to one of the partitions were exposed to a panel of antibodies that bind specifically to proteins in the cell membrane of mature red and white blood cells. Stem cells don't have these proteins in the membrane.

The cells that bound the antibodies were eliminated and the remaining cells were labeled with a fluorescent color dye that sits tightly between the fatty layers of the membrane of cells. These cells were then injected into female mice that had been irradiated, which destroys the cells in the bone marrow. After two days, the stem cells were recovered from the bone marrow of the female mice, and only those cells with the brightest color were used in the subsequent part of the study. The bright color indicated that the cells had not yet divided, assuring the researchers that these cells had the greatest transformative potential.

In the second part of the study, one of these bright-colored cells was plucked out of solution and transplanted into other female mice that had been irradiated. By killing the bone marrow, the stem cell would be forced to generate cells to repopulate the bone marrow of the recipient female mouse. Thirty female mice received the stem cell and five of the mice survived 11 months. Cells containing Y chromosomes were found in multiple organs in all five of these surviving mice.

This collaborative study was conducted by Neil Theise, Sonya Hwang, and Rebekah Gardner from NYU School of Medicine; Diane Krause and Octavian Henegariu from Yale; and Saul Sharkis, Sara Neutzel, and Michael Collector from Johns Hopkins. It was supported by grants from the National Institutes of Health, the American Liver Foundation, the Mary Lea Johnson Richards Research Institute, and the Robert Krieger Memorial Fund.


Story Source:

The above story is based on materials provided by New York University Medical Center And School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

New York University Medical Center And School Of Medicine. "Researchers Discover The Ultimate Adult Stem Cell." ScienceDaily. ScienceDaily, 4 May 2001. <www.sciencedaily.com/releases/2001/05/010504082859.htm>.
New York University Medical Center And School Of Medicine. (2001, May 4). Researchers Discover The Ultimate Adult Stem Cell. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/05/010504082859.htm
New York University Medical Center And School Of Medicine. "Researchers Discover The Ultimate Adult Stem Cell." ScienceDaily. www.sciencedaily.com/releases/2001/05/010504082859.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins